|1.||Humpel, C: 2 articles (01/2001 - 07/2000)|
|2.||Singh, Jagdish: 1 article (06/2015)|
|3.||Lipp, Lindsey: 1 article (06/2015)|
|4.||Layek, Buddhadev: 1 article (06/2015)|
|5.||Baumgart-Vogt, Eveline: 1 article (11/2014)|
|6.||Hahn-Kohlberger, Petra: 1 article (11/2014)|
|7.||Michel, Vera: 1 article (11/2014)|
|8.||Vogt, Julia-Franziska: 1 article (11/2014)|
|9.||Ahlemeyer, Barbara: 1 article (11/2014)|
|10.||Bernt, William: 1 article (08/2014)|
10/15/1999 - "Improved lipid-mediated gene transfer in C6 glioma cells and primary glial cells using FuGene."
07/01/2000 - "In this study we investigated the lipid-mediated gene transfer into primary neurons in vitro by using the novel nonliposomal lipid FuGene and compared it to primary glia and malignant C6 glioma cells. "
07/01/2000 - "Lipid-mediated gene transfer into primary neurons using FuGene: comparison to C6 glioma cells and primary glia."
01/01/2001 - "Our data show that the lipid FuGene is useful to transfer DNA in vitro into 3T3 fibroblasts, C6 glioma cells, and primary astroglia and to express the respective enzyme. "
07/01/2000 - "FuGene-mediated gene transfer was useful to transfer the reporter gene beta-galactosidase into C6 glioma cells, primary glia, and primary neurons. "
02/01/2010 - "Thus, the aim of this study was to explore the anti-cancer effect of AT 2 over-expression on lung adenocarcinoma cells in vitro using adenoviral (Ad), FuGENE, and nanoparticle vectors. "
01/01/2008 - "The End-pcDNA3.1 plasmid diluted in the transfection reagent FuGENE was injected into the tumors (around 100 mm(2)), and paclitaxel was injected i.p. "
|3.||Hepatocellular Carcinoma (Hepatoma)
09/01/2012 - "In this report, we investigated in vitro gene delivery to both primary rat hepatocytes and Huh7.5.1 cells (a hepatoma cell line) using a number of viral and non-viral methods, including Lipofectamine 2000, FuGene HD, Nucleofection, Magnetofection, and lentiviruses. "
11/01/2014 - "First, we tried to optimize the transfection of the hepatoma cell line HepG2 with PEX5 siRNA using different commercially available liposomal and non-liposomal transfection reagents (Lipofectamine(®) 2000, FuGENE 6, HiPerFect(®), INTERFERin™, RiboJuice™) as well as microporation using the Neon™ Transfection system. "
06/01/2012 - "The pAAV-CD151, pAAV-GFP and pAAV-CD151-AAA mutant plasmids were constructed and used to transiently transfect PC3 cells (a prostatic carcinoma 3 cell line) by the mediation of Fugene HD. "
08/18/2014 - "To identify an optimal vector for gene delivery, we compared the transfection activities and efficiencies of Glycofect, Metafectene, Metafectene Pro, Metafectene Easy and FuGENE HD, using the OSCC cell line, HSC-3, and the cervical carcinoma cell line, HeLa. "
|5.||Breast Ductal Carcinoma
|1.||Adenocarcinoma of lung
|2.||Indicators and Reagents (Reagents)
|3.||DNA (Deoxyribonucleic Acid)
|6.||Small Interfering RNA (siRNA)